[COGT] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[COGT] Cogent Biosciences, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 4.65%
YoY- -74.51%
Quarter Report
COGT's Result
COGT's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 0 312 1,020 2,043 2,331 -
PBT -55,382 -35,062 -19,084 -49,983 -11,923 -10,168 -7,000 41.13%
Tax -855 -1,759 -115 -7,608 -349 -405 -100 42.97%
NP -55,382 -33,303 -19,084 -49,983 -11,923 -10,168 -7,000 41.13%
Tax Rate - - - - - - - -
Total Cost 55,382 33,303 19,084 50,295 12,943 12,211 9,331 34.53%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 -16,020.19 -1,168.92 -497.70 -300.30 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.64 -0.48 -0.48 -5.07 -1.56 -1.36 -1.20 -9.94%
EPS Diluted -0.64 -0.48 -0.48 -5.07 -1.56 -1.36 -0.95 -6.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.